Soracan gum / hyaluronic acid antibacterial hydrogel as well as preparation method and application thereof
By performing amide reaction and oxidation treatment on sorgum and hyaluronic acid, combined with the antibacterial agent PHMB, a self-healing sorgum/hyaluronic acid antibacterial hydrogel was constructed, solving the irreversible adhesion of traditional dressings and network structure. Problem, effective healing and biocompatibility of wounds are achieved.
Patent Information
- Application Number
- CN202310589700.8
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2023-05-22
- Publication Date
- 2024-11-22
- Estimated Expiration
- 2043-05-22
AI Technical Summary
Traditional wound dressings are easily adhered to the new granulation tissue when taken out, causing secondary damage. Moreover, the network structure of the hydrogel is irreversible, easy to invade bacteria, difficult to achieve self-repair and effectively promote wound healing.
Adipic acid dihydrazide reacts with sorgum to form hydrazide groups, combines sodium periodate oxidation of hyaluronic acid to construct a self-healing hydrogel through dynamic acyl hydrazone bonds, and introduces the antibacterial agent polyhexamethylene biguanide (PHMB), forming a sorgate/hyaluronic acid antibacterial hydrogel.
The self-healing characteristics, biocompatibility and antibacterial properties of the hydrogel were achieved, which promoted wound healing, and significantly improved the healing efficiency of wound tissue in animal experiments.
Smart Images

Figure CN118987329A_ABST
Abstract
Description
Technical Field
[0001] The invention belongs to the field of medical devices, and specifically relates to a sola glue / hyaluronic acid antibacterial hydrogel and a preparation method and application thereof. Background Art
[0002] The information disclosed in this background technology section is only intended to enhance the understanding of the overall background of the invention, and should not necessarily be regarded as an admission or any form of suggestion that the information constitutes the prior art already known to a person skilled in the art.
[0003] As a protective barrier against harsh environments, human skin often clashes and inevitably produces trauma. When the skin is damaged, the damaged area is susceptible to bacterial infection, which hinders wound healing and even causes serious complications. Scientists are committed to developing wound dressings for clinical practice. Traditional wound dressings such as gauze and cotton have good hygroscopicity and can absorb wound exudate, but their promotion of wound healing is limited. In order to promote wound healing, researchers have improved gauze and cotton, introduced antibacterial drugs into cotton and gauze, such as loading antibacterial polymers to prevent bacterial infection of wounds. However, the problems that gauze and cotton have always existed cannot be changed. Cotton and gauze will adhere to the newly grown granulation tissue and cause pain when removed, causing secondary damage. Compared with dry dressings that may cause tissue damage when removed, wet dressings not only prevent damage to the wound but also increase the rate of epithelialization. Hydrogels have good flexibility and biocompatibility. Hydrogels with antibacterial activity are considered to be good candidates for wet wound dressings. However, the internal network structure of traditional hydrogels is irreversible. When damaged by external forces, the hydrogels will crack and lead to bacterial invasion. Therefore, it is of great significance to prepare a hydrogel dressing with good antibacterial properties and self-healing ability in wound repair. Summary of the invention
[0004] In order to overcome the above problems, the present invention provides a sora glue / hyaluronic acid antibacterial hydrogel and its preparation method and application. The present invention uses adipic acid dihydrazide to react with sora glue to obtain sora glue with a hydrazide group at the end, and hyaluronic acid is oxidized with sodium periodate to obtain hyaluronic acid with an aldehyde group. The two are used as raw materials to construct a hydrogel with self-repairing properties based on a dynamic acylhydrazone bond, and the antibacterial agent polyhexamethylene biguanide (PHMB) is introduced to improve the antibacterial ability of the hydrogel.
[0005] In order to achieve the above technical objectives, the present invention adopts the following technical solutions:
[0006] The first aspect of the present invention provides a method for preparing a sola gel / hyaluronic acid hydrogel, the method comprising:
[0007] Adipic acid dihydrazide (ADH) was grafted onto Salecan (Sal) through amide reaction to obtain Adipic acid dihydrazide-modified Salecan (Sal-ADH); Hyaluronic acid (Hyaluronic acid, HA) was oxidized with sodium periodate to obtain Oxidized hyaluronic acid (OHA); Adipic acid dihydrazide-modified Salecan and oxidized hyaluronic acid were reacted with Schiff base to obtain Sal-ADH / OHA hydrogel.
[0008] The second aspect of the present invention provides a sora gel / hyaluronic acid hydrogel prepared by the above preparation method.
[0009] The third aspect of the present invention provides a method for preparing a sola gel / hyaluronic acid antibacterial hydrogel, the method comprising:
[0010] Polyhexamethylene biguanide hydrochloride (PHMB) was added to the above-mentioned Salar gum / hyaluronic acid hydrogel, and the mixture was stirred thoroughly to obtain Salar gum / hyaluronic acid antibacterial (PHMB / Sal-ADH / OHA) hydrogel.
[0011] The fourth aspect of the present invention provides a sola gel / hyaluronic acid antibacterial hydrogel prepared by the above method.
[0012] A fifth aspect of the present invention provides a wound dressing, comprising the above-mentioned sora glue / hyaluronic acid antibacterial hydrogel.
[0013] A sixth aspect of the present invention provides the use of the above-mentioned sola glue / hyaluronic acid antibacterial hydrogel in skin repair, wound suturing or wearable devices.
[0014] The beneficial effects of the present invention are:
[0015] (1) The present invention prepares PHMB / Sal-ADH / OHA hydrogel by blending adipic acid dihydrazide-modified sal-adhesive with oxidized hyaluronic acid and PHMB. The hydrogel has good self-healing properties, biocompatibility, antibacterial properties, and wound healing performance. It is an ideal biomaterial and provides a new idea for the development of hydrogel wound dressings.
[0016] (2) The sola gel / hyaluronic acid hydrogel prepared by the present invention exhibits good swelling behavior in liquid; the macroscopic healing experiment and continuous strain and recovery scanning test results of the hydrogel show that the hydrogel has self-healing properties.
[0017] (3) The cell survival rate of the sola gel / hyaluronic acid antibacterial hydrogel prepared by the present invention after co-incubation with L929 cells for 24 hours and 48 hours was determined by MTT experiment, and it was found that the cell survival rate of all hydrogel groups was above 80%. In the live / dead cell staining experiment, the vast majority of L929 cells maintained a spindle-shaped morphology and were evenly distributed and green living cells, with basically no red blood cells and dead cells. In addition, in the hemolysis experiment, the hemolysis rate of the hydrogel was within 5%, proving that the hydrogel has good biocompatibility.
[0018] (4) Animal wound experiments further demonstrated that the sola gel / hyaluronic acid antibacterial hydrogel prepared by the present invention can promote the healing process of wound tissue. BRIEF DESCRIPTION OF THE DRAWINGS
[0019] The accompanying drawings in the specification, which constitute a part of the present invention, are used to provide a further understanding of the present invention. The exemplary embodiments of the present invention and their descriptions are used to explain the present invention and do not constitute improper limitations on the present invention.
[0020] Figure 1 : A scanning electron micrograph of the sola gel / hyaluronic acid hydrogel prepared in Example 1;
[0021] Figure 2 : The swelling performance diagram of the sola gel / hyaluronic acid hydrogel prepared in Example 1, wherein a is the hydrogel swelling rate diagram, and b is the equilibrium swelling rate diagram;
[0022] Figure 3 : The water vapor permeability graph of the sola gel / hyaluronic acid hydrogel prepared in Example 1;
[0023] Figure 4 : The self-healing diagram of the sola glue / hyaluronic acid hydrogel prepared in Example 1;
[0024] Figure 5 : The mechanical properties diagram of the Sora glue / hyaluronic acid hydrogel prepared in Example 1, wherein a is the compression strain curve and b is the compression strength;
[0025] Figure 6 : The continuous strain recovery scanning test diagram of the sola gel / hyaluronic acid hydrogel prepared in Example 1, a is Gel-0.6, b is Gel-0.7, c is Gel-0.8, d is Gel-0.9, and e is Gel-1.0;
[0026] Figure 7 The scanning electron micrograph of the sola glue / hyaluronic acid antibacterial hydrogel prepared in Example 3 is shown in FIG.
[0027] Figure 8: Drug release diagram of Sora gel / hyaluronic acid antibacterial hydrogel prepared in Example 3, wherein a is the drug release diagram of different antibacterial gels, and b is the drug release diagram of SOP-0.10 in PBS solutions with different pH values (pH=5, 7.4);
[0028] Fig. 9 : The injectability analysis diagram of the sola glue / hyaluronic acid antibacterial hydrogel prepared in Example 3, wherein a is a macro injection diagram, and b is a diagram showing the change of hydrogel viscosity with shear rate.
[0029] Fig.10 : The antibacterial performance diagram of the sola gel / hyaluronic acid antibacterial hydrogel prepared in Example 3, wherein a is the hydrogel inhibition zone diagram, and b is the OD value of the antibacterial hydrogel;
[0030] Fig.11 : The cell survival rate diagram of the sola gel / hyaluronic acid antibacterial hydrogel extract prepared in Example 3 and L929 cells incubated for different time periods, where a is 24 hours and b is 48 hours.
[0031] Fig.12 =Live / dead staining of L929 cells cultured with hydrogel extract for 1 day;
[0032] Fig.13 The hemolysis diagram of the sola gel / hyaluronic acid antibacterial hydrogel prepared in Example 3, wherein a is a diagram of the hemolysis effect of the hydrogel, and b is a diagram of the hemolysis rate of the hydrogel;
[0033] Fig.14 a is the wound healing diagram of mice, where a is the wound healing change, and b is the wound healing rate. DETAILED DESCRIPTION
[0034] It should be noted that the following detailed descriptions are exemplary and are intended to provide further explanation of the present invention. Unless otherwise specified, all technical and scientific terms used in the present invention have the same meanings as those commonly understood by those skilled in the art to which the present invention belongs.
[0035] Sal polysaccharide-based hydrogels are usually copolymerized with toxic crosslinkers or monomers to enhance the mechanical properties of the hydrogels. The hydrogels prepared in this way have great safety risks, which limits their clinical use. Hyaluronic acid lacks active groups that can quickly gel, so it is necessary to modify sora glue and hyaluronic acid to broaden their application prospects in wound dressings. The first typical embodiment of the present invention provides a method for preparing sora glue / hyaluronic acid hydrogel, the method comprising:
[0036] Sora glue is grafted with adipic acid dihydrazide through amide reaction to obtain adipic acid dihydrazide Sora glue; hyaluronic acid is oxidized by sodium periodate to obtain oxidized hyaluronic acid; adipic acid dihydrazide Sora glue and oxidized hyaluronic acid are reacted by Schiff base to obtain Sora glue / hyaluronic acid hydrogel.
[0037] In one or more embodiments, the specific synthesis method of the sora gum grafted with adipic acid dihydrazide to obtain adipic acid dihydrazide sora gum through an amide reaction is as follows: sora gum and adipic acid dihydrazide are added to water, stirred at room temperature for 25 to 40 minutes, and the pH is adjusted to 4 to 5 with a hydrochloric acid solution; 1-ethyl-(3-dimethylaminopropyl) carbodiimide (EDC) is added, and the pH is adjusted to 4 to 5 with a hydrochloric acid solution again, and stirring is continued for 3 to 5 hours; NaOH solution is added to adjust the pH to 7 to terminate the reaction; the reaction solution is placed in a dialysis bag for dialysis, and the solution after dialysis is freeze-dried for 30 to 50 hours to obtain adipic acid dihydrazide sora gum.
[0038] Preferably, the mass ratio of the sora gum, adipic acid dihydrazide, 1-ethyl-(3-dimethylaminopropyl)carbodiimide and water is 0.2-05:1.8-2.2:05-0.6:18-220, preferably 0.3:2.08:0.57:200.
[0039] Preferably, the sola gum and adipic acid dihydrazide are added to water and stirred at room temperature for 30 minutes.
[0040] Preferably, the concentration of the hydrochloric acid solution is 0.05-0.15 mol / L, more preferably 0.1 mol / L.
[0041] Preferably, the concentration of the NaOH solution is 0.05-0.15 mol / L, more preferably 0.1 mol / L.
[0042] Preferably, the pH of the hydrochloric acid solution is adjusted to 4.75.
[0043] Preferably, the molecular weight cutoff of the dialysis bag is 7000Da.
[0044] Preferably, the specific method of dialysis is: dialysis with 0.1 mol / L NaCl aqueous solution for 24 hours, then dialysis with 25% ethanol for 24 hours, and finally dialysis with pure water for 4 days, changing the dialysate at least three times a day during the dialysis process, and removing unreacted substances by dialysis.
[0045] Preferably, the freeze-drying time is 48 hours.
[0046] In one or more embodiments, the specific synthesis method of oxidized hyaluronic acid obtained by oxidizing hyaluronic acid with sodium periodate is as follows: NaIO4 and HA are dissolved in water respectively to obtain NaIO4 solution and HA solution, the NaIO4 solution is added dropwise to the HA solution, stirred for 5 to 7 hours in a dark environment, and then ethylene glycol is added to terminate the reaction, and stirring is continued for 0.5 to 2 hours. The reaction solution is placed in a dialysis bag for dialysis, and the solution after dialysis is freeze-dried for 30 to 50 hours to obtain oxidized hyaluronic acid.
[0047] Preferably, the mass ratio of NaIO4 to HA is 1.5-2.5:1.1-1.3, preferably 2.0:1.13; the concentration of the NaIO4 solution is 0.4-6 mol / L, preferably 0.5 mol / L; the concentration of the HA solution is 8-12 mg / mL, preferably 10 mg / mL.
[0048] Preferably, the stirring is carried out in the dark for 6 hours.
[0049] Preferably, the mass ratio of NaIO4 to ethylene glycol is 1.5-2.5:0.5-0.6, preferably 2.0:1.1.
[0050] Preferably, the stirring time is 1 hour.
[0051] Preferably, the specific method of dialysis is: dialysis with pure water for 3 days, changing the dialysate at least three times a day during the dialysis process, and removing unreacted substances through dialysis.
[0052] Preferably, the freeze-drying time is 48 hours.
[0053] In one or more embodiments, the specific method for obtaining the Sora gum / hyaluronic acid hydrogel by the Schiff base reaction of the adipic acid dihydrazide Sora gum and oxidized hyaluronic acid is as follows: dissolving the adipic acid dihydrazide Sora gum in water, heating it in a water bath at 70 to 90° C. for 15 to 25 minutes, then adding oxidized hyaluronic acid, stirring for 20 to 40 seconds, and cooling and standing to obtain the Sora gum / hyaluronic acid hydrogel.
[0054] Preferably, the temperature of the water bath is 80° C. and the heating lasts for 20 min.
[0055] Preferably, the stirring time is 30s.
[0056] Preferably, the mass ratio of the adipic acid dihydrazide sora gum to the oxidized hyaluronic acid is 0.6-1.0:0.2, and more preferably 0.8:0.2.
[0057] Preferably, the concentration of the adipic acid dihydrazide sora gum is 0.6-1.0 wt%, preferably 0.8 wt%; and the concentration of the oxidized hyaluronic acid is 0.2 wt%.
[0058] A second typical embodiment of the present invention provides a sola gel / hyaluronic acid hydrogel prepared by the above preparation method.
[0059] A third typical embodiment of the present invention provides a method for preparing a sola gel / hyaluronic acid antibacterial hydrogel, the method comprising:
[0060] Polyhexamethylene biguanide hydrochloride (PHMB) was added to the Salomon gum / hyaluronic acid hydrogel and stirred thoroughly to obtain the Salomon gum / hyaluronic acid antibacterial (PHMB / Sal-ADH / OHA) hydrogel.
[0061] In one or more embodiments, the sola gel / hyaluronic acid hydrogel needs to be prepared before use.
[0062] In one or more embodiments, the concentration of the polyhexamethylene biguanide hydrochloride is 0.05 wt% to 0.20 wt%, preferably 0.05 wt%, 0.10 wt%, 0.15 wt%, or 0.20 wt%.
[0063] In one or more embodiments, the stirring time is 20 to 40 seconds, preferably 30 seconds.
[0064] A fourth typical embodiment of the present invention provides a sola gel / hyaluronic acid antibacterial hydrogel prepared by the above method.
[0065] A fifth typical embodiment of the present invention provides a wound dressing, wherein the wound dressing comprises the above-mentioned sora gum / hyaluronic acid hydrogel and / or the above-mentioned sora gum / hyaluronic acid antibacterial hydrogel.
[0066] A sixth typical embodiment of the present invention provides the use of the above-mentioned sora glue / hyaluronic acid antibacterial hydrogel and / or the above-mentioned sora glue / hyaluronic acid antibacterial hydrogel in skin repair, wound suture or wearable devices.
[0067] In order to enable those skilled in the art to more clearly understand the technical solution of the present invention, the technical solution of the present invention will be described in detail below in conjunction with specific embodiments.
[0068] Example 1: (Preparation of Sora Glue / Hyaluronic Acid Hydrogel)
[0069] 0.3g Sal was dissolved in 200mL pure water, 2.08g ADH powder was added to the solution, stirred at room temperature for 30min, 0.1mol / L HCl solution was used to adjust the pH to 4.75, and then 0.57g EDC powder was added to dissolve, and the pH was adjusted to 4.75 with 0.1mol / L HCl solution again, and the reaction was continued for 4 hours after stirring, and 0.1mol / L NaOH solution was added to adjust the pH to 7 to terminate the reaction. The obtained reaction solution was added to a dialysis bag (molecular weight cutoff 7000Da), first dialyzed with 0.1mol / L NaCl aqueous solution for 24h, then dialyzed with 25% ethanol for 24h, and finally dialyzed with pure water for 4 days. The dialysate was changed at least three times a day during the dialysis process, and the unreacted substances were removed by dialysis. The dialyzed solution was freeze-dried for 48h to obtain Sal-ADH, which was placed in a desiccator for storage.
[0070] Weigh 2.0g HA powder and dissolve it in 200mL pure water to prepare a solution with a concentration of 10mg / mL. Dissolve 1.13g NaIO4 in 10.55mL pure water (concentration of 0.5mol / L), then add the prepared NaIO4 solution dropwise to the HA solution, stir in the dark for 6h, then add 1mL ethylene glycol to terminate the reaction, continue stirring for 1h, put the solution after the reaction into a dialysis bag (molecular weight cutoff 7000Da), dialyze with pure water for 3 days, and freeze-dry the dialyzed solution for 48h to obtain OHA.
[0071] A certain amount of Sal-ADH powder was weighed and fully dissolved in pure water. After heating in a water bath at 80°C for 20 min, it was stirred and mixed with OHA in different proportions. After stirring for 30 s, the rotor was taken out and allowed to stand to form a gel after cooling. The proportions of Sal-ADH and OHA in each gel are shown in Table 1.
[0072] Table 1 Composition of Sal-ADH / OHA hydrogel
[0073]
[0074] Example 2
[0075] In this example, the sola gel / hyaluronic acid hydrogel prepared in Example 1 was characterized.
[0076] like Figure 1As shown in the figure, the microscopic morphology of the hydrogel was observed by scanning electron microscopy. The hydrogel showed a porous structure. As the concentration of Sal-ADH increased, the hydrogel network gradually became denser and the average pore size showed a decreasing trend. This is because the hydrazide group on Sal-ADH provides an active site for the OHA crosslinker to form an acylhydrazone bond. The higher the concentration of Sal-ADH, the higher the crosslinking density and the tighter the microstructure of the hydrogel. This structure is conducive to the rapid absorption of large amounts of water and the timely transportation of cell nutrients and metabolic secretion waste, and is conducive to cell adhesion, proliferation and secretion of cytokines.
[0077] An ideal wound dressing should absorb exudate from the wound site, and the water absorption or swelling behavior of the hydrogel in water allows the penetration of nutrients and bioactive molecules. Figure 2 As shown in a, within the first 10 hours, the Sal-ADH / OHA hydrogels showed strong water absorption capacity. When the Sal-ADH concentration was 0.6wt%, the gel reached equilibrium swelling in 15 hours, and then the swelling degree showed a downward trend and then stabilized. This is because the hydrogel network structure at this time is relatively loose, and Sal-ADH and OHA contain a large number of hydroxyl groups, which causes the gel to swell excessively and disintegrate. As the Sal-ADH concentration increases, the hydrogel tends to stabilize after reaching equilibrium swelling. This is because the internal structure of the gel gradually becomes denser and the hydrogel structure is relatively stable. As the Sal-ADH concentration increases from 0.6% to 1.0%, the equilibrium swelling degree of the hydrogel decreases from 3133.5% to 2290.9%. This is because the higher the Sal-ADH concentration, the higher the cross-linking density of the hydrogel. Therefore, due to the high cross-linking density, the hydrogel is difficult to swell, which increases the stability and structure of the hydrogel network, resulting in a decrease in the ability of the hydrogel to absorb liquid and a decrease in the swelling rate. The swelling degrees of all hydrogels were above 2000%, confirming that the hydrogels exhibited good swelling behavior in liquids, indicating the potential of Sal-ADH / OHA hydrogels in wound dressings.
[0078] The water vapor transmission rate is a parameter for testing the suitability of a material for external applications such as wound dressings. For wound dressing materials, the moisture permeability should be neither too high, which would result in extreme water loss, nor too low, which could result in the accumulation of exudate. Figure 3 As shown, the water vapor permeability of different hydrogels is 3300~3050g / m 2 / day, the surface hydrogel has moderate permeability.
[0079] Hydrogel wound dressings may be subjected to mechanical forces and deform, wear, or even damage during use. Hydrogels with automatic self-healing capabilities can recover from damage, effectively extending their service life. Figure 4As shown in the figure, two hydrogel films, one stained with methyl orange and the other unstained, were attached together. After one hour, the hydrogel automatically healed into a complete piece. From a macroscopic point of view, the hydrogel has self-healing properties. This property may be due to the fact that the acylhydrazone bond inside the hydrogel is a dynamic chemical bond. The acylhydrazone bond can be spontaneously formed at room temperature through the Schiff base reaction, and finally the self-healing property of the hydrogel is exhibited.
[0080] like Figure 5 As shown in the figure, as the Sal-ADH concentration increases from 0.6% to 0.9%, the compressive stress increases from 17.18Kpa to 74.77Kpa. This is because the cross-linking density of the hydrogel increases, resulting in a significant improvement in the mechanical properties of the hydrogel. When the Sal-ADH concentration is 1.0wt%, the compressive strain breaks at about 35%, and the hydrogel breaks only at 50%. This shows that when the cross-linking density of the hydrogel is too large, the hydrogel becomes brittle and the compressive stress decreases. The compression modulus of the hydrogel also maintains the same trend as the pressure-strain curve.
[0081] The mechanical properties and self-healing properties of the hydrogel were tested by rheological recovery test. Figure 6 As shown in b, after the strain increases from 1% to 400%, the storage modulus (G') of the hydrogel decreases and is less than the loss modulus (G"), and it is in a sol state. When the strain decreases from 400% to 1%, the storage modulus G' of the hydrogel rises rapidly to the original value, and the hydrogel recovers to a gel structure. This shows that these hydrogels have better recovery ability. These results show that the prepared Sal-ADH / OHA hydrogel has self-healing properties, which may be because the group forming the hydrogel is an acylhydrazone bond, which is a dynamic chemical bond. The acylhydrazone group breaks when the gel structure is destroyed, but can re-react with a Schiff base reaction at low strain to form an acylhydrazone bond to form a hydrogel, so that the storage modulus G' value is restored to the original data. In addition, the equilibrium creep compliance (Jo) was determined, which is defined as the ratio of G' and G" calculated from the end creep measurement area. Gel-0.8 is the highest among all composite hydrogels, at 96.31%, while the recovery rates of other hydrogels are between 44.9% and 75.9%. The results show that although different hydrogels can achieve partial structural recovery, they still lose some integrity under strain. Among the Sal-ADH / OHA hydrogels with different ratios, Gel-0.8 has a higher recovery rate and exhibits better self-healing properties.
[0082] Example 3 (Preparation of a Sora Glue / Hyaluronic Acid Antibacterial Hydrogel)
[0083] A certain amount of Sal-ADH powder was weighed and fully dissolved in pure water. After heating in a water bath at 80°C for 20 min, it was stirred and mixed with OHA in different proportions. Different concentrations of PHMB were added and stirred for 30 s, then the rotor was taken out and allowed to stand to form a gel after cooling. The concentrations of Sal-ADH and OHA in the antibacterial gel were 0.8wt% and 0.2wt%, and the concentrations of PHMB were 0.05wt%, 0.10wt%, 0.15wt% and 0.20wt%, respectively. The antibacterial gels were named SOP-0.05, SOP-0.10, SOP-0.15 and SOP-0.20, respectively.
[0084] The morphology of SOP hydrogels in the freeze-dried state was examined by SEM. Figure 7 As shown in Figure 2, SOP hydrogel has a porous and dense network structure with a pore size ranging from 200 to 100 μm. The addition of PHMB enhances the network structure of the gel, reduces the pore size of the hydrogel, and enhances the cross-linking density of the hydrogel.
[0085] Example 4
[0086] The antibacterial gels SOP-0.05, SOP-0.10, SOP-0.15 and SOP-0.20 prepared in Example 3 were subjected to drug release analysis.
[0087] The prepared SOP-0.05, SOP-0.10, SOP-0.15, and SOP-0.20 antibacterial hydrogels were placed in a centrifuge tube containing 10 mL of PBS solution, which was placed in a constant temperature oscillator at 37°C and 100 rpm. Samples were taken out at different time intervals, and an equal volume of PBS buffer was added to the centrifuge tube after taking 2 mL of solution each time until the end of the set time node. The absorbance of the solution was measured at 235 nm using an ultraviolet spectrophotometer, and a release curve was made to determine the concentration of PHMB in the sample. The results are shown in Figure 2. Figure 8 shown.
[0088] from Figure 8 As can be seen in a, within the first 8 hours, the drug showed rapid release, with a certain burst release behavior. In the later stage, PHMB was released in a sustained and stable manner. The dense network of the composite material acts as a physical barrier to fix PHMB, which also helps to delay the diffusion of PHMB. When the PHMB content is high, the electrostatic interaction between the negative charges of sora gum and hyaluronic acid and PHMB is strong, and the PHMB loaded into the gel is difficult to overcome the constraints of sora gum and hyaluronic acid and fully released. When the PHMB content is low, the negative charges of sora gum and hyaluronic acid are neutralized by PHMB, and the constraints on PHMB are weakened, which significantly increases the release amount of loaded PHMB.
[0089] from Figure 8As can be seen in Figure b, initially, due to the large difference in concentration, the drug release rate of the PBS solution was very fast. Gradually, the drug release rates of the two PBS solutions showed differences. The hydrogel showed obvious pH-sensitive drug release behavior and showed the fastest drug release rate in the PBS solution with pH = 5. This is because the acylhydrazone bonds in the hydrogel network broke under the acidic microenvironment, releasing PHMB faster. Afterwards, the hydrogel showed a stable and long-term release, but the rate slowed down.
[0090] Example 5
[0091] The injectability of the antibacterial gels SOP-0.05, SOP-0.10, SOP-0.15 and SOP-0.20 prepared in Example 3 was analyzed.
[0092] like Fig. 9 As shown in a, the hydrogel precursor liquid is injected into a syringe, and then the hydrogel is squeezed into deionized water using a syringe needle. The hydrogel still maintains the characteristics of a gel and does not break, indicating that the hydrogel has injectable properties.
[0093] like Fig. 9 As shown in Figure b, the viscosity of the hydrogel decreases with increasing shear rate, indicating that the hydrogel has good shear thinning properties. From the perspective of clinical application, this property is very advantageous in wound treatment because the hydrogel can be evenly applied to the wound and fill irregular defects.
[0094] Example 5
[0095] The in vitro antibacterial properties of the antibacterial gels SOP-0.05, SOP-0.10, SOP-0.15, and SOP-0.20 prepared in Example 3 were evaluated using Escherichia coli and Staphylococcus aureus.
[0096] Inhibition zone method: First, prepare solid culture medium and liquid culture medium. The preparation method of solid culture medium is as follows: take 25g LB broth and 15g agar powder, add 1000mL of deionized water, divide into conical bottles, place in autoclave at 121℃ for 20min, then take 15mL~20mL culture medium into sterilized disposable plastic dish, invert and store at 4℃ after cooling. Escherichia coli and Staphylococcus aureus were activated and cultured at 37℃ and 140rpm for 12h, and the obtained bacterial suspension was diluted to the required concentration before use.
[0097] The hydrogel needs to be pre-treated and the hydrogel is prepared into a diameter of 15 mm and a height of 10 mm using a mold. After the hydrogel is formed, it is irradiated under ultraviolet light for 12 hours to prepare a sterile hydrogel. Take 100 μL of the diluted bacterial suspension (10 6CFU / mL), the bacterial suspension was evenly spread on the solid culture medium with a coating rod, the hydrogel was placed on the solid culture medium covered with the bacterial solution, inverted and cultured, and placed in a 37°C bacterial incubator for 24 hours, then taken out and the antibacterial activity was compared based on the inhibition zone. Fig.10 As shown in Figure a, as the concentration of PHMB increases, the size of the inhibition zone gradually increases. The antibacterial ability of PHMB comes from the fact that when PHMB comes into contact with bacteria, the positively charged PHMB interacts with the negatively charged phospholipids in the bacterial cell membrane, destroying the lipid bilayer and the integrity of the cell membrane, and then penetrates into the cytoplasm, resulting in ion leakage and loss of function of the bacterial cells, and ultimately leading to cell death. Due to the strong antibacterial activity of PHMB, SOP hydrogel shows strong antibacterial activity.
[0098] OD value method: 1 mL of hydrogel was added to a 24-well plate. After the plate was placed under UV light for 12 h, 1 mL of bacterial suspension (about 10 8 After culturing in an incubator for 24 h, the OD value at 600 nm was measured using a microplate reader. The smaller the OD value, the better the antibacterial effect.
[0099] like Fig.10 As shown in (b), the OD value of the bacterial suspension treated with SOP was much lower than that of the control group, indicating that SOP has good antibacterial activity.
[0100] Example 6
[0101] The cell compatibility of the antibacterial gels SOP-0.05, SOP-0.10, SOP-0.15 and SOP-0.20 prepared in Example 3.
[0102] MTT method: The four groups of SOP hydrogels were prepared into 20 mm and 4 mm thick discs. Before the experiment, the hydrogels needed to be pretreated. The sample treatment method was as follows:
[0103] First, the four groups of weighed hydrogels were soaked in 75% ethanol for 4 hours. The purpose of this step was to sterilize the hydrogels. Then the hydrogels were placed in sterile PBS for 3 rinses to remove the alcohol in the hydrogels. Then the hydrogels were placed in DEME culture medium (according to the hydrogel mass to culture medium volume ratio of 1g:10mL), incubated at 37℃ shaker (100rpm) for 24h, the hydrogels were removed from the culture medium, and the remaining solution was filtered and sterilized to obtain the hydrogel extract. The extract concentrations were 1, 5, 25, and 50mg / mL, respectively. Prepare MTT solution: weigh 50mg of MTT powder and dissolve it in 10mL of PBS solution. The final concentration was 5mg / mL of the stock solution. After filtering with a 0.22μm sterile filter head, it was stored at -20℃ away from light.
[0104] Second, mouse fibroblasts (L929) were revived and suspended in DMEM medium containing 10% fetal bovine serum and 1% double antibody. L929 cells in the logarithmic growth phase were digested with trypsin containing EDTA and diluted with fresh medium to obtain 5×10 5 Take 100 μL of the cell suspension and add it to a 96-well cell culture plate to make the seeding density 5×10 4 The cells were placed in a 37°C cell culture incubator and incubated for 24 h.
[0105] Third, after the cells are fully grown, the culture medium solution in the 96-well plate is removed, and 100 μL of hydrogel extract and 100 μL of fresh culture medium are added to the experimental group and the blank group, and the cells are incubated in a 37°C cell culture incubator for 24 hours and 48 hours. After 24 hours and 48 hours, the culture medium is removed, 150 μL of MTT solution is added to each well, and the cells are incubated in a 37°C cell culture incubator for 4 hours. The MTT solution is removed, and 150 μL of dimethyl sulfoxide (DMSO) is added to each well containing cells in the 96-well plate, and then the plate is placed in a 37°C shaker for 10 minutes away from light. Finally, the absorbance at 570 nm is measured with an ELISA reader, and the cell survival rate is calculated using the following formula:
[0106]
[0107] Among them, A t is the absorbance of the cell culture wells added with hydrogel extract, A0 is the absorbance of the culture wells with sterile water, and Ae is the absorbance of the culture wells with DMEM medium.
[0108] Live / dead cell staining assay: Take 1 mL of cells at a density of 5×10 5 L929 cells were seeded at 100 μg / mL in a 24-well plate. After incubation for 1 day, the culture medium was removed, and 1 mL of hydrogel extract and fresh culture medium were added to the 24-well plate for the experimental group and the blank group, respectively, and then placed in a 37°C cell culture incubator for another day. The hydrogel extract and culture medium were removed, washed with PBS, and 250 μL of AM / PI mixture was added. The plates were incubated at room temperature in the dark for 30 minutes, and the cell status was carefully observed and photographed using an inverted fluorescence microscope.
[0109] like Fig.11As shown in a and b, when L929 cells were co-incubated with SOP hydrogel for 24 and 48 hours, the cell survival rates of the four groups of hydrogels exceeded 100%, indicating that sora gelatin and hyaluronic acid as part of the material itself can promote the proliferation of L929 cells. This is because these two polysaccharides provide nutrients for cell proliferation and differentiation. The decrease in cell survival rate of SOP-0.20 hydrogel may be related to the release of high concentrations of PHMB, but all cell survival rates exceeded 80%, indicating that the hydrogel loaded with PHMB has good cell compatibility for L929 cells.
[0110] like Fig.12 As shown, after 24 hours of co-incubation with the four groups of SOP hydrogels and blank hydrogel extracts, the vast majority of L929 cells maintained a spindle-shaped morphology and were evenly distributed and green living cells, with basically no red blood cells and dead cells, indicating that the hydrogels had no cytotoxicity to L929 cells, which would allow the hydrogels to be used as potential wound dressings.
[0111] Example 7
[0112] The hemolytic properties of the antibacterial gels SOP-0.05, SOP-0.10, SOP-0.15 and SOP-0.20 prepared in Example 3.
[0113] When blood comes into contact with materials, red blood cells may rupture, which is called hemolysis. The blood compatibility of the material can be reflected by measuring the absorbance value.
[0114] Take the blood of the rat, centrifuge it at 1000rpm for 10min to obtain red blood cells, wash the obtained red blood cells 3 times with PBS and dilute them to a concentration of 5% (v / v). Subsequently, different hydrogel samples (0.3mL) and red blood cells (0.7mL) were mixed and placed on a shaker at 37℃100rpm for 1h. After that, the mixture was centrifuged (1000rpm, 10min), 0.3mL of distilled water and 0.3mL of PBS were mixed with 0.7mL of red blood cell suspension (0.7mL) as positive and negative controls, respectively, and the absorbance at 540nm was recorded with an enzyme reader to calculate the hemolysis rate:
[0115]
[0116] Among them A s , A n and A p is the absorbance value of sample, negative control and positive control.
[0117] Fig.13This is the hemolysis diagram of SOP hydrogel. The PBS solution was used as the blank control group, and deionized water was used as the positive control group. The supernatants of the four groups of hydrogels and the blank control group were light yellow, and the positive control group was red, indicating that the SOP hydrogel did not produce hemolysis. The hemolysis rates of the four hydrogels were 0.37, 1.17, 1.83, and 2.34%, respectively. When the hemolysis rate of the material is within 5%, the material has good blood compatibility. This shows that the four hydrogels have good blood compatibility and will not produce toxic reactions to the blood.
[0118] Example 8
[0119] The antibacterial gels SOP-0.05, SOP-0.10, SOP-0.15 and SOP-0.20 prepared in Example 3 were used to perform wound healing promotion experiments.
[0120] A full-thickness skin defect model on the back of rats was established to test the function of hydrogel as a wound dressing to promote wound healing. The experiment used SD rats weighing 180-220g. In order to allow the rats to adapt to the environment, they were fed for one week before starting the experiment. Before the experiment, the mice were divided into 3 groups: (1) blank group; (2) commercial dressing 3M hydrocolloid dressing group; (3) hydrogel group. 10% chloral hydrate was injected intraperitoneally into the SD rats for anesthesia, and then the hair on the back of the SD male rats was removed with a shaver. Subsequently, a full-thickness skin wound with a diameter of 1.5 cm was created on the back of the rat with scissors, and 100 μL of bacterial suspension (10 8 CFU / mL) to create a bacterial environment, and then the rat wounds were treated with 3M dressings and hydrogel dressings respectively. The wounds were photographed on the 1st, 7th and 14th days to observe the healing status. The wound area was calculated using Image J software, and the calculation formula for the wound contraction rate (%) was:
[0121]
[0122] A0 is the area of the wound on day 0, A t is the area of the wound on day t
[0123] like Fig.14 As shown, at trauma day 0, all wounds were similar. By the 7th day, the wound sizes between the blank group, the hydrogel group, and the 3M dressing began to differ, and obvious wound closure could be found in the hydrogel group, with the wound areas of the commercial group and the gel group rats reduced to 65.17% and 68.70%, respectively, which were higher than those of the control group. On the 14th day, the wound closure areas of the blank group and the commercial dressing group increased, with wound healing rates of 90.01% and 95.55%, respectively, while the wound closure of the gel group was basically completed, and new hair began to cover the wound surface. This shows that the hydrogel has the best wound healing effect in rats.
Claims
1. A method for preparing a sola gel / hyaluronic acid hydrogel, characterized in that: The method comprises: Sora glue is grafted with adipic acid dihydrazide through amide reaction to obtain adipic acid dihydrazide Sora glue; hyaluronic acid is oxidized by sodium periodate to obtain oxidized hyaluronic acid; adipic acid dihydrazide Sora glue and oxidized hyaluronic acid are reacted by Schiff base to obtain Sora glue / hyaluronic acid hydrogel.
2. The preparation method according to claim 1, characterized in that The specific synthesis method of the sora gum grafted with adipic acid dihydrazide to obtain adipic acid dihydrazide sora gum through an amide reaction is as follows: sora gum and adipic acid dihydrazide are added to water, stirred at room temperature for 25 to 40 minutes, and the pH is adjusted to 4 to 5 with a hydrochloric acid solution; 1-ethyl-(3-dimethylaminopropyl) carbodiimide (EDC) is added, and the pH is adjusted to 4 to 5 with a hydrochloric acid solution again, and stirring is continued for 3 to 5 hours; NaOH solution is added to adjust the pH to 7 to terminate the reaction; the reaction solution is placed in a dialysis bag for dialysis, and the solution after dialysis is freeze-dried for 30 to 50 hours to obtain adipic acid dihydrazide sora gum.
3. The preparation method according to claim 1, characterized in that: The specific synthesis method of oxidized hyaluronic acid obtained by oxidizing hyaluronic acid with sodium periodate is as follows: NaIO4 and HA are dissolved in water respectively to obtain NaIO4 solution and HA solution, the NaIO4 solution is added dropwise to the HA solution, stirred for 5 to 7 hours in a dark environment, and then ethylene glycol is added to terminate the reaction, and stirring is continued for 0.5 to 2 hours, the reaction solution is placed in a dialysis bag for dialysis, and the solution after dialysis is freeze-dried for 30 to 50 hours to obtain oxidized hyaluronic acid.
4. The preparation method according to claim 1, characterized in that: The specific method for obtaining the Sora gum / hyaluronic acid hydrogel by the Schiff base reaction of the adipic acid dihydrazide Sora gum and oxidized hyaluronic acid is as follows: dissolving the adipic acid dihydrazide Sora gum in water, heating it in a water bath at 70 to 90° C. for 15 to 25 minutes, then adding oxidized hyaluronic acid, stirring for 20 to 40 seconds, cooling and standing to obtain the Sora gum / hyaluronic acid hydrogel.
5. Sora gel / hyaluronic acid hydrogel prepared by the preparation method according to any one of claims 1 to 4.
6. A method for preparing a sola gel / hyaluronic acid antibacterial hydrogel, characterized in that: The method comprises: Add polyhexamethylene biguanide hydrochloride to the sora gum / hyaluronic acid hydrogel according to claim 5, and stir thoroughly to obtain the sora gum / hyaluronic acid antibacterial hydrogel.
7. The preparation method according to claim 6, characterized in that: The sola gel / hyaluronic acid hydrogel needs to be prepared before use.
8. The sola gel / hyaluronic acid antibacterial hydrogel prepared by the preparation method according to any one of claims 6 to 7.
9. A wound dressing, characterized in that: The wound dressing comprises the sora gum / hyaluronic acid hydrogel according to claim 5 and / or the sora gum / hyaluronic acid antibacterial hydrogel according to claim 8.
10. Use of the sora glue / hyaluronic acid hydrogel according to claim 5 and / or the sora glue / hyaluronic acid antibacterial hydrogel according to claim 8 in skin repair, wound suturing or wearable devices.
Citation Information
Patent Citations
Application of soracan gum for preparing medicine for promoting skin wound healing
CN104116756A
Soracan gum polysaccharide-based cationic polymer hydrogel and preparation method thereof
CN108623821A
Antibacterial hydrogel based on imine bonds and acylhydrazone bonds and preparation method of antibacterial hydrogel
CN110894302A
pH-sensitive digestive tract injured mucosa protective glue and application thereof
CN111759858A
Composition for prophylaxis against pathogens and methods of use
WO2022217319A1
Cited By
Oxidized konjac glucomannan and hydrazide hyaluronic acid composite hydrogel as well as preparation method and application thereof
CN120459361A
Ultrathin breathable CMC adhesive bandage and preparation method thereof
CN122399081A
